Abstract
Introduction
Amantadine hydrochloride is an antiviral medication used as therapy for parkinsonism and as a cognitive enhancer. We report 2 cases of massive, acute ingestion of amantadine hydrochloride confirmed with serial serum levels.
Case Reports
A 47-year-old woman presented to the emergency department (ED) 30 minutes after ingesting 10 g of amantadine (150 mg/kg) by her report. Initial ECG revealed a sinus rhythm with rate of 93 bpm, and a QRS of 84 msec. While in the ED, the patient sustained a pulseless cardiac arrest and the monitor revealed ventricular tachycardia. She was successfully defibrillated. Postdefibrillation ECG showed a sinus rhythm (rate = 82 bpm), QRS of 236 msec, and QTc of 567 msec. The serum potassium was 1.0 mEq/L (1.0 mmol/L). The patient was given 300 ml (300 cc) 3% sodium chloride IV over 10 minutes. Ten minutes after completion of the hypertonic saline infusion, the patient’s ECG abnormalities resolved and the QRS was 88 msec. Her potassium was repleted over the next 11 hours postpresentation, and she also received an IV bolus of 4 g of magnesium sulfate immediately after the cardiac arrest. No further hypotension, dysrhythmia, conduction delay, or ectopy was noted during the patient’s hospital stay. The second case involved a 33-year-old female patient who presented 1 hour after ingesting 100 tablets of amantadine hydrochloride (100 mg/tab). Initial ECG revealed sinus tachycardia with a QRS of 113 msec, an R wave in lead aVR of 4–5 mm and a QTc of 526 msec. Her serum potassium was 3.0 mEq/L (3.0 mmol/L), her serum calcium was 9.4 mg/dl (2.35 mmol/L), and serum magnesium was 2.1 mg/dl (0.86 mmol/L) on labs drawn at initial presentation. The patient was intubated for airway protection, and her potassium was repleted and corrected over the next 9 hours. Her ECG abnormalities improved 8 hours after initial presentation and normalized at approximately 14 hours postingestion. The patient was discharged home 11 days after her ingestion.
Conclusion
Acute amantadine toxicity manifests with life-threatening cardiotoxicity. Concurrent, often profound, hypokalemia may complicate the administration of sodium bicarbonate in the management of cardiac dysrhythmias.
Keywords: amantadine, overdose, torsades, hypokalemia
Full Text
The Full Text of this article is available as a PDF (696.2 KB).
Footnotes
There was no outside funding of any kind used for this study.
References
- 1.Strong DK, Eisenstat DD, Bryson SM, Sitar DS, Arbus GS. Amantadine neurotoxicity in a pediatric patient with renal insufficiency. Ann Pharmacother. 1991;25:1175–1177. doi: 10.1177/106002809102501103. [DOI] [PubMed] [Google Scholar]
- 2.Snoey ER, Bessen HA. Acute psychosis after amantadine overdose. Ann Emerg Med. 1989;19(6):668–670. doi: 10.1016/S0196-0644(05)82473-4. [DOI] [PubMed] [Google Scholar]
- 3.Macchio GJ, Ito V, Sahgal V. Amantadine-induced coma. Arch Phys Med Rehabil. 1993;74:1119–1120. doi: 10.1016/0003-9993(93)90072-I. [DOI] [PubMed] [Google Scholar]
- 4.Berkowitz CD. Treatment of acute amantadine toxicity with physostigmine. J Pediatr. 1979;95(1):144–145. doi: 10.1016/S0022-3476(79)80111-0. [DOI] [PubMed] [Google Scholar]
- 5.Sartori M, Pratt CM, Young JB. Torsade de pointe: malignant cardiac arrhythmia induced by amantadine poisoning. Am J Med. 1984;77(2):388–391. doi: 10.1016/0002-9343(84)90728-9. [DOI] [PubMed] [Google Scholar]
- 6.Cook PE, Dermer SW, McGurk T. Fatal overdose with amantadine. Can J Psychiatry. 1986;31(8):757–758. doi: 10.1177/070674378603100814. [DOI] [PubMed] [Google Scholar]
- 7.Simpson DM, Ramos F, Ramirez LF. Death of a psychiatric patient from amantadine poisoning. Am J Psych. 1988;145(2):267–268. doi: 10.1176/ajp.145.2.267. [DOI] [PubMed] [Google Scholar]
- 8.Brown CR, Hernandez S, Kelly MT. Hyperthermia and death from amantadine overdose. Vet Hum Toxicol. 1987;29(6):463–463. [Google Scholar]
- 9.Pimentel L, Hughes B. Amantadine toxicity presenting with complex ventricular ectopy and hallucinations. Pediatr Emerg Care. 1991;7(2):89–92. doi: 10.1097/00006565-199104000-00007. [DOI] [PubMed] [Google Scholar]
- 10.Yang CC, Deng JF. Anticholinergic syndrome with severe rhabdomyolysis: an unusual feature of amantadine toxicity. Intensive Care Med. 1997;23(3):355–356. [PubMed] [Google Scholar]
- 11.Fahn S, Craddock G, Kumin G. Acute toxic psychosis from suicidal overdosage of amantadine. Arch Neurol. 1971;25:45–48. doi: 10.1001/archneur.1971.00490010055008. [DOI] [PubMed] [Google Scholar]
- 12.Lange KW, Riederer P. Glutaminergic drugs in Parkinson’s disease. Life Sci. 1994;55(25):2067–2075. doi: 10.1016/0024-3205(94)00387-4. [DOI] [PubMed] [Google Scholar]
- 13.Salata JJ, Jalife J, Megna JL, Alperovich G. Amantadine-induced diastolic depolarization and automaticity in ventricular muscle. Circ Res. 1982;51:722–732. doi: 10.1161/01.res.51.6.722. [DOI] [PubMed] [Google Scholar]
- 14.Hiraoka M, Hirano Y, Kawano S, Fan Z, Sawanobori T. Amantadine-induced afterpotentials and automaticity in guinea pig ventricular myocytes. Circ Res. 1989;65:880–893. doi: 10.1161/01.res.65.4.880. [DOI] [PubMed] [Google Scholar]
- 15.Aoki FY, Sitar DS. Clinical pharmacokinetics of amantadine hydrochloride. Clin Pharmacokinetic. 1988;14:35–51. doi: 10.2165/00003088-198814010-00003. [DOI] [PubMed] [Google Scholar]
- 16.Liu P, Cheng PJ, Ing TS, Daugirdas JT, Jeevanandhan R. In vitro binding of amantadine to plasma proteins. Clin Neuropharmacol. 1984;7:149–151. doi: 10.1097/00002826-198406000-00005. [DOI] [PubMed] [Google Scholar]